APOE4 is associated with an increased risk for AD by tau-mediated neurodegeneration and is also associated with reduced efficiency in many brain homeostatic pathways, including lipid transport, neuronal synaptic integrity and plasticity, and glucose metabolism [23]. This evidence concerns the gene MAPT and Alzheimer disease.